Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

1998-05

AUTHORS

Hyun Cheol Chung, Sun Young Rha, Joon Oh Park, Nae Choon Yoo, Joo Hang Kim, Jae Kyung Roh, Jin Sik Min, Kyong Sik Lee, Byung Soo Kim, Jin Ju Kim

ABSTRACT

The plasma urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and urokinase-type plasminogen activator receptor (uPAR) levels were measured in healthy volunteers and breast cancer patients. In pre-menopause healthy females, blood was sampled weekly during one menstruation cycle and menstruation phases (follicular, ovulatory, luteal) were determined by FSH/LH levels. uPA, PAI-1, and uPAR levels were at the nadir during ovulatory phase. uPA level was highest at follicular phase while PAI-1 level was highest at luteal phase. In comparison between pre- and post-menopause states, uPA and uPAR levels were higher in post-menopause state while PAI-1 level was higher in pre-menopause state. In breast cancer patients, uPA, PAI-1, and uPAR positive rates were low when we use the menopause-state-unmatched cut-off points. As we adjusted the cut-off points by menopause states, the PAI-1 positivity increased mainly in post-menopause cancer patients. These findings suggest that there is a minor but possible sequential change of these molecules during menstruation cycle which might blur the pathological positivity in pre-menopause cancer patients. The pathological elevation of PAI-1 was well detected in post-menopause cancer patients, but this elevation did not correlate with tumor burden such as number of metastatic sites or metastatic location. In conclusion, adjustment of physiological changes of uPA, PAI-1, and uPAR is required in determining pathological elevation of the plasma levels in cancer patients, especially in females. More... »

PAGES

41-50

Identifiers

URI

http://scigraph.springernature.com/pub.10.1023/a:1005997421733

DOI

http://dx.doi.org/10.1023/a:1005997421733

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1002620976

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/9694610


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Breast Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Menstrual Cycle", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Plasminogen Activator Inhibitor 1", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Cell Surface", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Receptors, Urokinase Plasminogen Activator", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Urokinase-Type Plasminogen Activator", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chung", 
        "givenName": "Hyun Cheol", 
        "id": "sg:person.016554426212.74", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Rha", 
        "givenName": "Sun Young", 
        "id": "sg:person.01036404665.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404665.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Park", 
        "givenName": "Joon Oh", 
        "id": "sg:person.012011721474.14", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011721474.14"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yoo", 
        "givenName": "Nae Choon", 
        "id": "sg:person.01232034433.81", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232034433.81"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Joo Hang", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Roh", 
        "givenName": "Jae Kyung", 
        "id": "sg:person.0767622633.82", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Min", 
        "givenName": "Jin Sik", 
        "id": "sg:person.01353452051.75", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353452051.75"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Kyong Sik", 
        "id": "sg:person.01122621505.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122621505.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea", 
          "id": "http://www.grid.ac/institutes/grid.15444.30", 
          "name": [
            "Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Byung Soo", 
        "id": "sg:person.01073443534.33", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073443534.33"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department of Clinical Pathology, Inha University College of Medicine, Sungnam, Korea", 
          "id": "http://www.grid.ac/institutes/grid.202119.9", 
          "name": [
            "Department of Clinical Pathology, Inha University College of Medicine, Sungnam, Korea"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kim", 
        "givenName": "Jin Ju", 
        "id": "sg:person.0626356353.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626356353.18"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "sg:pub.10.1007/bf01833260", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009892128", 
          "https://doi.org/10.1007/bf01833260"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1038/bjc.1994.74", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1022984019", 
          "https://doi.org/10.1038/bjc.1994.74"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1998-05", 
    "datePublishedReg": "1998-05-01", 
    "description": "The plasma urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and urokinase-type plasminogen activator receptor (uPAR) levels were measured in healthy volunteers and breast cancer patients. In pre-menopause healthy females, blood was sampled weekly during one menstruation cycle and menstruation phases (follicular, ovulatory, luteal) were determined by FSH/LH levels. uPA, PAI-1, and uPAR levels were at the nadir during ovulatory phase. uPA level was highest at follicular phase while PAI-1 level was highest at luteal phase. In comparison between pre- and post-menopause states, uPA and uPAR levels were higher in post-menopause state while PAI-1 level was higher in pre-menopause state. In breast cancer patients, uPA, PAI-1, and uPAR positive rates were low when we use the menopause-state-unmatched cut-off points. As we adjusted the cut-off points by menopause states, the PAI-1 positivity increased mainly in post-menopause cancer patients. These findings suggest that there is a minor but possible sequential change of these molecules during menstruation cycle which might blur the pathological positivity in pre-menopause cancer patients. The pathological elevation of PAI-1 was well detected in post-menopause cancer patients, but this elevation did not correlate with tumor burden such as number of metastatic sites or metastatic location. In conclusion, adjustment of physiological changes of uPA, PAI-1, and uPAR is required in determining pathological elevation of the plasma levels in cancer patients, especially in females.", 
    "genre": "article", 
    "id": "sg:pub.10.1023/a:1005997421733", 
    "inLanguage": "en", 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "49"
      }
    ], 
    "keywords": [
      "plasminogen activator inhibitor-1", 
      "breast cancer patients", 
      "cancer patients", 
      "PAI-1 levels", 
      "urokinase-type plasminogen activator", 
      "plasma urokinase-type plasminogen activator", 
      "activator inhibitor-1", 
      "pathological elevation", 
      "menstruation cycle", 
      "uPAR levels", 
      "receptor levels", 
      "healthy females", 
      "FSH/LH levels", 
      "plasminogen activator", 
      "inhibitor-1", 
      "menopause state", 
      "pathological positivity", 
      "LH levels", 
      "tumor burden", 
      "metastatic sites", 
      "menstruation phase", 
      "follicular phase", 
      "plasma levels", 
      "metastatic locations", 
      "ovulatory phase", 
      "luteal phase", 
      "pathological changes", 
      "healthy volunteers", 
      "patients", 
      "uPA levels", 
      "sequential changes", 
      "physiological changes", 
      "positivity", 
      "positive rate", 
      "elevation", 
      "females", 
      "levels", 
      "activator", 
      "blood", 
      "volunteers", 
      "burden", 
      "uPAR", 
      "changes", 
      "conclusion", 
      "findings", 
      "adjustment", 
      "rate", 
      "cycle", 
      "sites", 
      "number", 
      "comparison", 
      "point", 
      "phase", 
      "state", 
      "cut", 
      "molecules", 
      "location"
    ], 
    "name": "Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients", 
    "pagination": "41-50", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1002620976"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1023/a:1005997421733"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "9694610"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1023/a:1005997421733", 
      "https://app.dimensions.ai/details/publication/pub.1002620976"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-05-20T07:20", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220519/entities/gbq_results/article/article_287.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1023/a:1005997421733"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1023/a:1005997421733'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1023/a:1005997421733'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1023/a:1005997421733'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1023/a:1005997421733'


 

This table displays all metadata directly associated to this object as RDF triples.

236 TRIPLES      22 PREDICATES      97 URIs      87 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1023/a:1005997421733 schema:about N224f849117b54c8c856d041b1af6e57a
2 N4493d749288d489bbc92fe1234337764
3 N5164299931ab46f2b85ed415d750b0c6
4 N65ea43628a1c4ec3bc8b54fd4c8eb9fb
5 N6c09e737c4be4be4a5ae62664c554caf
6 N6e1428f17db7400b874211a128af41ca
7 N786795f65fc54f34a78d78ad9b36c004
8 N8ebe9b5be52b4d64938110acf947c833
9 N9a3eba27edaa409ea2c5b01b28dc4571
10 Nc507081f3e1d44708f90dfad9bf30ec5
11 Nc5de044cda924205b126e0312bd27e13
12 anzsrc-for:11
13 anzsrc-for:1112
14 schema:author Nc242ce8f8fbc4c51abd3199d7835747e
15 schema:citation sg:pub.10.1007/bf01833260
16 sg:pub.10.1038/bjc.1994.74
17 schema:datePublished 1998-05
18 schema:datePublishedReg 1998-05-01
19 schema:description The plasma urokinase-type plasminogen activator (uPA), plasminogen activator inhibitor-1 (PAI-1), and urokinase-type plasminogen activator receptor (uPAR) levels were measured in healthy volunteers and breast cancer patients. In pre-menopause healthy females, blood was sampled weekly during one menstruation cycle and menstruation phases (follicular, ovulatory, luteal) were determined by FSH/LH levels. uPA, PAI-1, and uPAR levels were at the nadir during ovulatory phase. uPA level was highest at follicular phase while PAI-1 level was highest at luteal phase. In comparison between pre- and post-menopause states, uPA and uPAR levels were higher in post-menopause state while PAI-1 level was higher in pre-menopause state. In breast cancer patients, uPA, PAI-1, and uPAR positive rates were low when we use the menopause-state-unmatched cut-off points. As we adjusted the cut-off points by menopause states, the PAI-1 positivity increased mainly in post-menopause cancer patients. These findings suggest that there is a minor but possible sequential change of these molecules during menstruation cycle which might blur the pathological positivity in pre-menopause cancer patients. The pathological elevation of PAI-1 was well detected in post-menopause cancer patients, but this elevation did not correlate with tumor burden such as number of metastatic sites or metastatic location. In conclusion, adjustment of physiological changes of uPA, PAI-1, and uPAR is required in determining pathological elevation of the plasma levels in cancer patients, especially in females.
20 schema:genre article
21 schema:inLanguage en
22 schema:isAccessibleForFree false
23 schema:isPartOf N0c887bac264840aa9c36a78b490f10e2
24 Nde52afbf38cd4b2987333f77a4fcec50
25 sg:journal.1092777
26 schema:keywords FSH/LH levels
27 LH levels
28 PAI-1 levels
29 activator
30 activator inhibitor-1
31 adjustment
32 blood
33 breast cancer patients
34 burden
35 cancer patients
36 changes
37 comparison
38 conclusion
39 cut
40 cycle
41 elevation
42 females
43 findings
44 follicular phase
45 healthy females
46 healthy volunteers
47 inhibitor-1
48 levels
49 location
50 luteal phase
51 menopause state
52 menstruation cycle
53 menstruation phase
54 metastatic locations
55 metastatic sites
56 molecules
57 number
58 ovulatory phase
59 pathological changes
60 pathological elevation
61 pathological positivity
62 patients
63 phase
64 physiological changes
65 plasma levels
66 plasma urokinase-type plasminogen activator
67 plasminogen activator
68 plasminogen activator inhibitor-1
69 point
70 positive rate
71 positivity
72 rate
73 receptor levels
74 sequential changes
75 sites
76 state
77 tumor burden
78 uPA levels
79 uPAR
80 uPAR levels
81 urokinase-type plasminogen activator
82 volunteers
83 schema:name Physiological and pathological changes of plasma urokinase-type plasminogen activator, plasminogen activator inhibitor-1, and urokinase-type plasminogen activator receptor levels in healthy females and breast cancer patients
84 schema:pagination 41-50
85 schema:productId N68ba7ee299454a3cbe8fb28c7f8dbad8
86 N6d3c13f29f6a40239e85a0bd4c89c279
87 Nd83f735135f54731871fbddebcbf41c7
88 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002620976
89 https://doi.org/10.1023/a:1005997421733
90 schema:sdDatePublished 2022-05-20T07:20
91 schema:sdLicense https://scigraph.springernature.com/explorer/license/
92 schema:sdPublisher N045a99298c5d4b8ebf5dd0e294954842
93 schema:url https://doi.org/10.1023/a:1005997421733
94 sgo:license sg:explorer/license/
95 sgo:sdDataset articles
96 rdf:type schema:ScholarlyArticle
97 N045a99298c5d4b8ebf5dd0e294954842 schema:name Springer Nature - SN SciGraph project
98 rdf:type schema:Organization
99 N0c887bac264840aa9c36a78b490f10e2 schema:volumeNumber 49
100 rdf:type schema:PublicationVolume
101 N1b0c8b6d66be4dbabeeec6d6909f191d rdf:first sg:person.0767622633.82
102 rdf:rest N9b08b068fe7243a4a920ed3c62069b9c
103 N224f849117b54c8c856d041b1af6e57a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Urokinase-Type Plasminogen Activator
105 rdf:type schema:DefinedTerm
106 N2437f7bac2d74bf8aa3967bcde15da7a schema:affiliation grid-institutes:grid.15444.30
107 schema:familyName Kim
108 schema:givenName Joo Hang
109 rdf:type schema:Person
110 N4493d749288d489bbc92fe1234337764 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
111 schema:name Receptors, Urokinase Plasminogen Activator
112 rdf:type schema:DefinedTerm
113 N4ae430a18e174bfdbf31574c0bb73a60 rdf:first sg:person.0626356353.18
114 rdf:rest rdf:nil
115 N5164299931ab46f2b85ed415d750b0c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
116 schema:name Middle Aged
117 rdf:type schema:DefinedTerm
118 N65ea43628a1c4ec3bc8b54fd4c8eb9fb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
119 schema:name Breast Neoplasms
120 rdf:type schema:DefinedTerm
121 N68ba7ee299454a3cbe8fb28c7f8dbad8 schema:name dimensions_id
122 schema:value pub.1002620976
123 rdf:type schema:PropertyValue
124 N6c09e737c4be4be4a5ae62664c554caf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Male
126 rdf:type schema:DefinedTerm
127 N6d3c13f29f6a40239e85a0bd4c89c279 schema:name doi
128 schema:value 10.1023/a:1005997421733
129 rdf:type schema:PropertyValue
130 N6e1428f17db7400b874211a128af41ca schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
131 schema:name Adult
132 rdf:type schema:DefinedTerm
133 N786795f65fc54f34a78d78ad9b36c004 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
134 schema:name Menstrual Cycle
135 rdf:type schema:DefinedTerm
136 N8ebe9b5be52b4d64938110acf947c833 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
137 schema:name Plasminogen Activator Inhibitor 1
138 rdf:type schema:DefinedTerm
139 N9a3eba27edaa409ea2c5b01b28dc4571 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
140 schema:name Female
141 rdf:type schema:DefinedTerm
142 N9b08b068fe7243a4a920ed3c62069b9c rdf:first sg:person.01353452051.75
143 rdf:rest Ne1805aed73584723991a0ab844f52127
144 Na0d267de2a70456e9a621165954fcc47 rdf:first sg:person.012011721474.14
145 rdf:rest Ne65ad1d9e40f422ba2fdd4ff1a452b44
146 Nc242ce8f8fbc4c51abd3199d7835747e rdf:first sg:person.016554426212.74
147 rdf:rest Nfd42339c206846a2aeaeacb25db901ad
148 Nc507081f3e1d44708f90dfad9bf30ec5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
149 schema:name Humans
150 rdf:type schema:DefinedTerm
151 Nc5de044cda924205b126e0312bd27e13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
152 schema:name Receptors, Cell Surface
153 rdf:type schema:DefinedTerm
154 Ncb669a13d6a64aa1b2559df1a195cf4e rdf:first N2437f7bac2d74bf8aa3967bcde15da7a
155 rdf:rest N1b0c8b6d66be4dbabeeec6d6909f191d
156 Nd83f735135f54731871fbddebcbf41c7 schema:name pubmed_id
157 schema:value 9694610
158 rdf:type schema:PropertyValue
159 Nde52afbf38cd4b2987333f77a4fcec50 schema:issueNumber 1
160 rdf:type schema:PublicationIssue
161 Ne1805aed73584723991a0ab844f52127 rdf:first sg:person.01122621505.36
162 rdf:rest Nf64e4b96382c43a7a0c85f58929e4dd3
163 Ne65ad1d9e40f422ba2fdd4ff1a452b44 rdf:first sg:person.01232034433.81
164 rdf:rest Ncb669a13d6a64aa1b2559df1a195cf4e
165 Nf64e4b96382c43a7a0c85f58929e4dd3 rdf:first sg:person.01073443534.33
166 rdf:rest N4ae430a18e174bfdbf31574c0bb73a60
167 Nfd42339c206846a2aeaeacb25db901ad rdf:first sg:person.01036404665.54
168 rdf:rest Na0d267de2a70456e9a621165954fcc47
169 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
170 schema:name Medical and Health Sciences
171 rdf:type schema:DefinedTerm
172 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
173 schema:name Oncology and Carcinogenesis
174 rdf:type schema:DefinedTerm
175 sg:journal.1092777 schema:issn 0167-6806
176 1573-7217
177 schema:name Breast Cancer Research and Treatment
178 schema:publisher Springer Nature
179 rdf:type schema:Periodical
180 sg:person.01036404665.54 schema:affiliation grid-institutes:grid.15444.30
181 schema:familyName Rha
182 schema:givenName Sun Young
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01036404665.54
184 rdf:type schema:Person
185 sg:person.01073443534.33 schema:affiliation grid-institutes:grid.15444.30
186 schema:familyName Kim
187 schema:givenName Byung Soo
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01073443534.33
189 rdf:type schema:Person
190 sg:person.01122621505.36 schema:affiliation grid-institutes:grid.15444.30
191 schema:familyName Lee
192 schema:givenName Kyong Sik
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122621505.36
194 rdf:type schema:Person
195 sg:person.012011721474.14 schema:affiliation grid-institutes:grid.15444.30
196 schema:familyName Park
197 schema:givenName Joon Oh
198 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012011721474.14
199 rdf:type schema:Person
200 sg:person.01232034433.81 schema:affiliation grid-institutes:grid.15444.30
201 schema:familyName Yoo
202 schema:givenName Nae Choon
203 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01232034433.81
204 rdf:type schema:Person
205 sg:person.01353452051.75 schema:affiliation grid-institutes:grid.15444.30
206 schema:familyName Min
207 schema:givenName Jin Sik
208 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01353452051.75
209 rdf:type schema:Person
210 sg:person.016554426212.74 schema:affiliation grid-institutes:grid.15444.30
211 schema:familyName Chung
212 schema:givenName Hyun Cheol
213 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016554426212.74
214 rdf:type schema:Person
215 sg:person.0626356353.18 schema:affiliation grid-institutes:grid.202119.9
216 schema:familyName Kim
217 schema:givenName Jin Ju
218 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0626356353.18
219 rdf:type schema:Person
220 sg:person.0767622633.82 schema:affiliation grid-institutes:grid.15444.30
221 schema:familyName Roh
222 schema:givenName Jae Kyung
223 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0767622633.82
224 rdf:type schema:Person
225 sg:pub.10.1007/bf01833260 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009892128
226 https://doi.org/10.1007/bf01833260
227 rdf:type schema:CreativeWork
228 sg:pub.10.1038/bjc.1994.74 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022984019
229 https://doi.org/10.1038/bjc.1994.74
230 rdf:type schema:CreativeWork
231 grid-institutes:grid.15444.30 schema:alternateName Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea
232 schema:name Yonsei Cancer Research Institute, Yonsei Cancer Center, Department of Internal Medicine, General Surgery, Yonsei University College of Medicine, Seoul, Korea
233 rdf:type schema:Organization
234 grid-institutes:grid.202119.9 schema:alternateName Department of Clinical Pathology, Inha University College of Medicine, Sungnam, Korea
235 schema:name Department of Clinical Pathology, Inha University College of Medicine, Sungnam, Korea
236 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...